# Rheumatoid Arthritis:Tolerance Induction by Mixed Chimerism

> **NCT00282412** · PHASE1 · TERMINATED · sponsor: **Northwestern University** · enrollment: 4 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **BIOLOGICAL:** Hematopoietic Stem Cell Transplantation
- **DRUG:** Fludarabine
- **DRUG:** Cyclophosphamide
- **DRUG:** Campath 1H
- **DRUG:** GCSF
- **DRUG:** Cyclosporins
- **DRUG:** Mycophenolate Mofetil

## Key facts

- **NCT ID:** NCT00282412
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2002-09
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** No participant enrolled for three years. No plan to continue study.
- **Last updated:** 2018-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00282412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00282412, "Rheumatoid Arthritis:Tolerance Induction by Mixed Chimerism". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00282412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*